Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-139
Closed -$2.04K 2820
2023
Q3
$2.04K Buy
139
+119
+595% +$1.85K ﹤0.01% 2120
2023
Q2
$354 Buy
+20
New +$339 ﹤0.01% 2576
2023
Q1
Sell
-192
Closed -$3.76K 2909
2022
Q4
$3.76K Hold
192
﹤0.01% 1957
2022
Q3
$4K Buy
192
+146
+317% +$2.95K ﹤0.01% 1800
2022
Q2
$1K Sell
46
-64
-58% -$1.5K ﹤0.01% 2372
2022
Q1
$3K Buy
110
+55
+100% +$1.51K ﹤0.01% 1882
2021
Q4
$2K Hold
55
﹤0.01% 1829
2021
Q3
$1K Hold
55
﹤0.01% 1785
2021
Q2
$2K Hold
55
﹤0.01% 1649
2021
Q1
$1K Buy
55
+24
+77% +$492 ﹤0.01% 1800
2020
Q4
$1K Hold
31
﹤0.01% 1695
2020
Q3
$0 Buy
+31
New +$478 ﹤0.01% 1836

Other funds holding TBI

Lindbrook Capital's TBI Position: Q4 2023 in Review

Lindbrook Capital sold out of Trueblue (TBI) in Q4 2023, closing a stake of 139 shares — an estimated $2.04K sold.

Lindbrook Capital first reported a position in TBI in Q3 2020 and held it in 12 quarters. The position peaked at $4K in Q3 2022. 152 funds tracked by Wall St. Rank hold TBI as of Q4 2023.

  • Lindbrook Capital reported no remaining Trueblue position as of Q4 2023 after selling out during the quarter.
  • Lindbrook Capital sold 139 Trueblue shares in Q4 2023, an estimated $2.04K.
  • Lindbrook Capital first reported a position in Trueblue in Q3 2020 and held it in 12 quarters.
  • Lindbrook Capital's Trueblue position peaked at $4K in Q3 2022.
  • 152 funds tracked by Wall St. Rank held Trueblue as of Q4 2023.

Based on Lindbrook Capital's 13F filing for Q4 2023, filed 1 Feb 2024.